As 2025 comes to a close, OriGen Biomedical is proud to reflect on another year of growth, innovation, and meaningful impact. Guided by our mission to provide life-saving products for critical cell therapy, we remain deeply committed to advancing healthcare through the power of science, collaboration, and purpose. Every milestone this year reflects the dedication of our employees, whose work continues to improve patient outcomes around the world.
In 2025, OriGen welcomed 61 new team members, bringing our current total full-time employees to approximately 175. This growth underscores our ongoing investment in people and our capacity to meet the demands of a rapidly evolving industry. From manufacturing to marketing, every department has played an essential role in maintaining product availability, supporting our customers, and driving innovation.
OriGen produced nearly 3 million units this year and continues to have a global reach of 72 countries through our trusted distributors and international partnerships. We also participated in six major trade shows and conferences, connecting with leaders and innovators across the cell and gene therapy landscape. These events provided valuable opportunities to showcase our products, strengthen collaborations, and stay at the forefront of advancing patient care.
We were also honored to be recognized as a Top Workplace by the Austin American-Statesman for the third consecutive year. This award, based on confidential employee feedback collected by Energage LLC, reflects our ongoing dedication to building a culture rooted in trust, purpose, and connection. It’s a powerful reminder that our people are at the heart of everything we do.
Throughout the year, we’ve continued to invest in process improvements, automation, and employee development programs to strengthen efficiency and support career growth. We also expanded our community involvement through employee engagement initiatives and events that connect our team to OriGen’s mission of improving lives.
2025 Milestones & Achievements
- OriGen Biomedical Announces $500 Scholarship to Austin-Area High School Students Seeking to Pursue a Career in STEM
- Handling Guidelines for Optimum Use When Using Your CryoStore FLEX Bag
- OriGen Biomedical Announces Strategic Partnership with Blood Centers of America
- Celebrating Lab Week 2025
- OriGen Biomedical President & CEO Featured on She Leads Biotech Podcast
- Why FEP Matters: A Technical Look at Cell Culture Bag Performance
- Celebrating Our 2025 Scholarship Recipient: Congratulations, Leah!
- OriGen Biomedical President & CEO Featured on The Entrepreneur’s Chair Podcast
- Selecting the Right Tubing Materials: Advantages in Sealing, Welding, and Cryopreservation
- OriGen Biomedical Walks to Bring Light to the Darkness of Cancer
- Austin American-Statesman Names OriGen Biomedical a Winner of the Greater Austin Top Workplaces 2025 Award
- OriGen Biomedical Opens Applications for 2026–2027 STEM Scholarship
As we look toward 2026, we remain focused on advancing innovative technologies, supporting our global partners, and delivering excellence to every customer. We extend our deepest gratitude to our employees, distributors, and customers who make our success possible. Together, we’ll continue pushing the boundaries of what’s possible in cell therapy and regenerative medicine.
Stay connected and follow our journey by subscribing to our quarterly newsletter here. Here’s to continued innovation, collaboration, and purpose in 2026!
